HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japan drives anti-aging skin-care market

This article was originally published in The Rose Sheet

Executive Summary

According to market research firm Mintel, the number of anti-aging skin-care products launched in Japan from 2007 to 2009 increased 85%, compared to a 27% increase in the U.S. during the same time period. Longevity among Japanese women leads the world and its steady increase, "traditional eating habits and long history of whitening beauty are just a few of the reasons this region continues to excel in the personal-care industry," Mintel's Hinako Sugioka says in Sept. 22 release. Sales of anti-aging skin-care products in the U.S. topped $1.8 bil. in 2009, with growth attributed to increased interest in health and wellbeing among women in the U.S. The market has also shown resilience to the economic downturn, with many women unwilling to stop buying anti-aging skin-care products, Sugioka noted

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017213

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel